F Carnino

Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.

M. Venturini, Andrea Michelotti, Lucia Del Mastro et al. · Journal of Clinical Oncology · 1996 · 162 citations

Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

Angiolo Gadducci, F Carnino, S. Chiara et al. · Gynecologic Oncology · 2000 · 142 citations · Full text

Medicine, Metronomic Therapy, Gynecology +8

Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.

Massimo Aglietta, Wanda Piacibello, F Sanavio et al. · Journal of Clinical Investigation · 1989 · 141 citations · Full text

Immunology, Blood Cell, Pathology +16

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

Pierfranco Conté, Milena Bruzzone, F Carnino et al. · Journal of Clinical Oncology · 1996 · 90 citations

Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma

Pierfranco Conté, Valentina Guarneri, Paolo Bruzzi et al. · Cancer · 2004 · 69 citations · Full text